Company Filing History:
Years Active: 2001
Title: Marina Taliani: Innovator in Biochemistry
Introduction
Marina Taliani is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of biochemistry, particularly in the development of methodologies for producing and purifying polypeptides. Her work is crucial for advancing therapeutic agents against Hepatitis C virus (HCV).
Latest Patents
Marina Taliani holds a patent for a methodology to produce, purify, and assay polypeptides with the proteolytic activity of the HCV NS3 protease. This innovative process allows for the expression and isolation of polypeptides in a pure, catalytically active form. The methodology is essential for discovering NS3 protease inhibitors and determining the three-dimensional structure of the NS3 protease. Additionally, her invention defines the necessary chemical and physical conditions for the proteolytic activity of these polypeptides. It also includes new compositions of matter, such as expression vectors containing nucleotide sequences capable of expressing the polypeptides in cultured cells. Furthermore, her work has led to the development of new compounds suitable for measuring proteolytic activity, which are useful in creating therapeutic agents against HCV.
Career Highlights
Marina Taliani is affiliated with the Istituto di Ricerche di Biologia Molecolare S.p.a., where she continues her research and development efforts. Her innovative methodologies have positioned her as a key figure in the biochemistry community, contributing to the fight against viral infections.
Collaborations
Marina has collaborated with notable colleagues, including Christian Steinkühler and Antonello Pessi. These partnerships have enhanced her research capabilities and broadened the impact of her inventions.
Conclusion
Marina Taliani's contributions to biochemistry, particularly in the development of methodologies for HCV research, highlight her role as an influential inventor. Her work not only advances scientific understanding but also paves the way for new therapeutic solutions.